Boji Medical's controlling shareholder unpledges significant stock

Guangzhou Boji Medical & Biotechnological Co. announced that its controlling shareholder, Wang Tingchun, has unpledged 7,603,600 shares. This represents 6.75% of his total holdings and 1.97% of the company's total share capital. The unpledging was processed through Everbright Securities and took effect on December 16, 2025, after being initiated on March 20, 2024. This move does not impact the company's operations or corporate governance.

Following this transaction, Wang Tingchun's cumulative pledged shares now total 19,000,000, which accounts for 16.86% of his total holdings and 4.93% of the company's total share capital. Of these pledged shares, 9,000,000 are restricted or frozen, representing 47.37% of his currently pledged stock. The remaining unpledged shares amount to 80,005,777, with 85.36% of these being restricted or frozen.

The company further confirmed that as of the announcement date, there are no freeze orders or auctions on Wang Tingchun's shares, and the pledged shares do not face any liquidation or compulsory transfer risks. Guangzhou Boji Medical & Biotechnological Co. stated it will continue to monitor the progress of share pledges and fulfill its disclosure obligations in compliance with relevant regulations.